Conditions: Eosinophilic Esophagitis
Keywords: Eosinophils Esophagitis Microscopy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 32
Healthy volunteers: no

Brief summary:
This study is designed to evaluate whether or not oral viscous budesonide is effective in treating children with Eosinophilic Esophagitis.

Detailed description:

Arms:
arm 1: oral viscous budesonide plus Prevacid arm 2: placebo plus Prevacid

Interventions: intervention 1: Budesonide plus Prevacid intervention 2: placebo plus Prevacid
Intervention descriptions: intervention 1: Budesonide is taken daily for three months. In addition, Prevacid is taken twice daily for three months. intervention 2: Placebo is taken daily for three months. In addition, Prevacid is taken twice daily for three months.

Protocol document: